Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing antibodies (bNAbs). The ...
May 30, 2024
0
93
An Oregon Health & Science University-developed platform for cytomegalovirus-based vaccines shows promise as a "shield" against cancer. The findings were recently published in the journal Science Advances.
May 29, 2024
0
60
Researchers have conducted the first comprehensive two-year laboratory characterization of the rare sub-type of the mosquito-borne Japanese encephalitis virus (JEV) that caused an unprecedented deadly outbreak in Australia ...
May 28, 2024
0
19
New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced "breakthrough" infections are especially well armed against future SARS-CoV-2 infections.
May 24, 2024
0
122
An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models. The vaccine could potentially help manage the outbreak of the H5N1 virus currently ...
May 23, 2024
0
32
In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes ...
May 22, 2024
0
72
Anti-malaria drugs have been a central component of a global public health effort that saw a 44% drop in the deadly mosquito-borne disease from 2000 to 2019, but progress has stalled as the parasites that cause malaria gain ...
May 22, 2024
0
6
Researchers have unveiled critical insights into how our genetic makeup influences the body's response to COVID-19 vaccines. The study, published in Nature Communications, may open new paths to personalized vaccination strategies.
May 22, 2024
0
43
HIV has proven a hard target for vaccine design. The most promising approach, germline-targeting (GT), proposes a series of immunizations: a first shot to activate inexperienced B cells—antibody-producing white blood cells—followed ...
May 21, 2024
0
17
The COVID-19 pandemic is over, but the virus that caused it is still here, sending thousands of people to the hospital each week and spinning off new variants with depressing regularity. The virus's exceptional ability to ...
May 18, 2024
2
145
